HMDB0004693 | 11H-14,15-EETA | 219535-29-2 | | C20H32O4 | 336.4657 336.230059512 | Not Available |
HMDB0004694 | 11,14,15-THETA | | | C20H34O5 | 354.481 354.240624198 | Not Available |
HMDB0004701 | 9,10-Epoxyoctadecenoic acid | | | C18H32O3 | 296.4449 296.23514489 | Not Available |
HMDB0004702 | 12,13-EpOME | | | C18H32O3 | 296.4449 296.23514489 | Not Available |
HMDB0004995 | Codeine | 76-57-3 | | C18H21NO3 | 299.3642 299.152143543 | Not Available |
HMDB0005012 | Olanzapine | 132539-06-1 | | C17H20N4S | 312.432 312.14086735 | Not Available |
HMDB0005017 | Pantoprazole | 102625-70-7 | | C16H15F2N3O4S | 383.37 383.075133083 | Not Available |
HMDB0005035 | Ondansetron | 99614-02-5 | | C18H19N3O | 293.363 293.152812245 | Not Available |
HMDB0005038 | Citalopram | 59729-33-8 | | C20H21FN2O | 324.3919 324.163791509 | Not Available |
HMDB0005050 | 15H-11,12-EETA | 877878-78-9 | | C20H32O4 | 336.4657 336.230059512 | Not Available |
HMDB0005782 | Hesperetin | 520-33-2 | | C16H14O6 | 302.2788 302.07903818 | Not Available |
HMDB0006552 | Aflatoxin B1 | 1162-65-8 | | C17H12O6 | 312.2736 312.063388116 | Not Available |
HMDB0006768 | 19-Oxoandrost-4-ene-3,17-dione | | | C19H24O3 | 300.3921 300.172544634 | Not Available |
HMDB0006769 | 19-Hydroxytestosterone | 2126-37-6 | | C19H28O3 | 304.4238 304.203844762 | Not Available |
HMDB0010738 | 1-Methylxanthine | 6136-37-4 | | C6H6N4O2 | 166.1374 166.049075456 | Not Available |
HMDB0011103 | 1,7-Dimethyluric acid | 33868-03-0 | | C7H8N4O3 | 196.1634 196.059640142 | Not Available |
HMDB0011136 | 19(S)-HETE | 79551-85-2 | | C20H32O3 | 320.4663 320.23514489 | Not Available |
HMDB0012242 | Ketoconazole | 65277-42-1 | | C26H28Cl2N4O4 | 531.431 530.148760818 | Not Available |
HMDB0012788 | 4-OH-Retinal | | | C20H28O2 | 300.4351 300.20893014 | Not Available |
HMDB0013839 | N-Desmethylaminopyrine | | | C12H15N3O | 217.267 217.121512117 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
HMDB0013840 | 3-Hydroxymethylantipyrine | 18125-49-0 | | C11H12N2O2 | 204.2252 204.089877638 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
HMDB0013845 | SR 49498 | | | C25H30N6O2 | 446.5447 446.243024234 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
|
HMDB0013846 | E-3179 | | | C22H21ClN6O | 420.895 420.146537031 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
|
HMDB0013862 | N-desmethylimatinib | | | C28H29N7O | 479.5762 479.243358585 | - Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
- Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. [PubMed:19754423 ]
|
HMDB0013866 | N-Desmethyltamoxifen | 31750-48-8 | | C25H27NO | 357.488 357.209264491 | - Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
- Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM: Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab Dispos. 2002 Aug;30(8):869-74. [PubMed:12124303 ]
|